TherapeuticsMD, Inc. (TXMD) financial statements and ratios from SEC XBRL: revenue $3.02M (TTM), net margin -18.8%, revenue growth 71.6% YoY, P/E 47.9. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $3.02M |
| Net Margin | -18.8% |
| Revenue Growth (YoY) | 71.6% |
| EPS Growth (YoY) | -73.7% |
| P/E Ratio | 47.9 |
| Price / Book | 0.88 |
| Price / Sales | 7.67 |
| Altman Z-Score | -34.08 (distress) |
| Sector P/E (Healthcare) | 21.7 |
TXMD overview · TXMD earnings · TXMD KPIs · TXMD investor relations · TXMD ownership · TXMD peers · TXMD filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.